Re: Zenith funding???
in response to
by
posted on
Jun 25, 2019 10:59AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
The cone of silence again from ZEL/ZCC management, i hope it means a deal at some point or an IPO, My guess is a partnership deal with Pfizer the obvious chice as they are already in bed with them, you never know it could be another BP waiting in the wings, Something has to give a some point whether managment is waiting for the TLD from the BOM trial to have more leverage or maybe that was the whole point , Having a BP buy the whole enchilida RVX and ZCC together,, who knows.... GLTA